Globavir Biosciences

Globavir Biosciences

A biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease.

All edits by  Golden AI 

Edits on 6 Oct, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 6 Oct, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
September 20, 2016
Edits on 25 Jun, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 25 Jun, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
6,000,000
Total funding amount (USD)
7,500,000
Golden AI
Golden AI edited on 25 Jun, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Globavir Biosciences funding round, September 2016
Golden AI"Funding autocalculation"
Golden AI edited on 25 Jun, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
2,000,000
Total funding amount (USD)
6,000,000
Golden AI
Golden AI edited on 25 Jun, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Globavir Biosciences funding round, January 2015
Golden AI"Funding autocalculation"
Golden AI edited on 25 Jun, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
2,000,000
Golden AI
Golden AI edited on 25 Jun, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Globavir Biosciences funding round, November 2012
Edits on 28 Oct, 2019
Golden AI"IBI-85"
Golden AI edited on 28 Oct, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Industry
Artificial intelligence (AI)
Edits on 8 Jul, 2019
Golden AI"Remove default description"
Golden AI edited on 8 Jul, 2019
Edits made to:
Description (-7 characters)
Topic thumbnail

Globavir Biosciences

Company

Edits on 17 Apr, 2019
Golden AI
Golden AI edited on 17 Apr, 2019
Edits made to:
Description (+7 characters)
Topic thumbnail

Globavir Biosciences

Company

Edits on 7 Mar, 2019
Golden AI
Golden AI edited on 7 Mar, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Is a
Company
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.